1.
Gene expression signatures differentiate adenocarcinoma of lung and breast origin in effusions
by Davidson, Ben, MD, PhD
Human pathology, 2012, Vol.43 (5), p.684-694
2.
Magnetic nanoparticle biodistribution following intratumoral administration
by Giustini, A J
Nanotechnology, 2011-08-26, Vol.22 (34), p.345101-1-5
3.
Electrochemical strategy for ultrasensitive detection of microRNA based on MNAzyme-mediated rolling circle amplification on a gold electrode
by Yang, Jianru
Mikrochimica acta (1966), 2016-09-26, Vol.183 (11), p.3061-3067
4.
Piperonal ciprofloxacin hydrazone induces growth arrest and apoptosis of human hepatocarcinoma SMMC-7721 cells
by Shi, Zhen-yu
Acta pharmacologica Sinica, 2012-02, Vol.33 (2), p.271-278
5.
Fluopsin C induces oncosis of human breast adenocarcinoma cells
by Ma, Li-sha
Acta pharmacologica Sinica, 2013, Vol.34 (8), p.1093-1100
6.
Evaluation of fractionated and repeated sonodynamic therapy by using dual frequency for murine model of breast adenocarcinoma
by Alamolhoda, Mahboobeh
Journal of therapeutic ultrasound, 2015, Vol.3 (1), p.10-10
7.
A study of Nigella sativa induced growth inhibition of MCF and HepG2 cell lines: An anti-neoplastic study along with its mechanism of action
by Reddy, Y
Pharmacognosy research, 2015-03-01, Vol.7 (2), p.193-197
8.
Role of phenolic compounds in nitric oxide synthase activity in colon and breast adenocarcinoma
by Cosan, Didem Turgut
Cancer biotherapy & radiopharmaceuticals, 2010-10, Vol.25 (5), p.577-580
9.
Endothelial cell intracellular Ca2+ concentration is increased upon breast tumor cell contact and mediates tumor cell transendothelial migration
by Lewalle, J M
Clinical & experimental metastasis, 1998-01, Vol.16 (1), p.21-29
10.
Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193)...
by Rao, Ruta D
Medical oncology (Northwood, London, England), 2010-09-28, Vol.28 (Suppl 1), p.39-47
11.
Influence of tumor derived fibroblasts and 1,25-dihydroxyvitamin D3 on growth of breast cancer cell lines
by LEFEBVRE, M. F
Breast cancer research and treatment, 1995, Vol.33 (3), p.189-197
12.
Radioimmunoscintigraphy in patients with breast adenocarcinoma using technetium-99m labelled monoclonal antibody 170H.82: report of a phase II study
by MCQUARRIE, S. A
European Journal of Nuclear Medicine, 1997, Vol.24 (4), p.381-389
13.
Breast cancer in previously burned skin: a postburn skin adnexal malignancy?
by Vögelin, E
Burns, 1997, Vol.23 (4), p.366-368
14.
Metastatic Breast Carcinoma of Prostatic Origin
by Kitano, Taiji
Urologia internationalis, 1983, Vol.38 (3), p.182-184
15.
A Multicentered, Randomized, Controlled Trial Comparing Radioguided Seed Localization to Standard Wire Localization for Nonpalpable, Invasive and in situ Breast Carcinomas
by Lovrics, Peter J
Annals of surgical oncology, 2011-04-30, Vol.18 (12), p.3407-3414
16.
Novel prognostic markers for patients with triple-negative breast cancer
by Zhou, Ling, MD
Human pathology, 2013, Vol.44 (10), p.2180-2187
17.
CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial
by Stebbing, Justin, Prof
The lancet oncology, 2017, Vol.18 (7), p.917-928
18.
A retrovirus-producing transformed mouse cell line derived from a human breast adenocarcinoma transplanted in a nude mouse
by Bowen, James M.
In Vitro, 1983-08, Vol.19 (8), p.635-641
19.
Characteristics and treatment of human epidermal growth factor receptor 2 positive breast cancer: 43,485 cases from the National Cancer Database treated in 2010 and 2011
by Killelea, Brigid K
The American journal of surgery, 2017-02, Vol.213 (2), p.426-432
20.
Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial
by van de Velde, Cornelis JH, Prof
The Lancet (British edition), 2011, Vol.377 (9762), p.321-331
